The Global External Ventricular Drain Market will grow at highest pace owing to increasing Demand for Minimally Invasive Neurosurgery
![]() |
| Global External Ventricular Drain Market |
External ventricular drains are CSF drainage catheters used to drain cerebrospinal fluid from the brain's ventricles to manage raised intracranial pressure. They are commonly used to treat hydrocephalus, intracranial hemorrhage, and tumors. External ventricular drains offer several advantages over other methods like minimally invasive insertion, accurate drainage of cerebrospinal fluid, and programmable valve systems to regulate drainage based on patient requirements. Rise in geriatric population prone to neurological disorders and growth of minimally invasive neurosurgery are key factors driving demand for external ventricular drains.
The Global External Ventricular Drain Market is estimated to be valued at US$ 10.63 Bn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Global External Ventricular Drain Market are
Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Neuromedex GmbH, Integra
LifeSciences, Müller Medical GmbH, B. Braun SE and Fuji Systems. Key players
are focusing on new product launches with advanced features to gain competitive
edge. For instance, in 2023 Medtronic launched Strata ventricular shunt series
with optimized flow regulation and MRI conditional design.
Growing prevalence of neurological disorders like hydrocephalus, tumors and
hemorrhage is a key factor driving demand for external ventricular drains. It
is estimated that over 1 million surgeries are performed annually to treat
hydrocephalus alone. Technological advancements like programmable valves,
wireless monitoring systems and MRI conditional materials are supporting
increased adoption of external ventricular drains over other drainage methods.
Market Trends
One of the key trends in the Global
External Ventricular Drain Market Demand is growing demand for
programmable valves to effectively manage cerebrospinal fluid drainage.
Programmable valves allow physicians to non-invasively adjust drainage based on
patient requirements avoiding multiple surgeries. Another trend is increasing
adoption of MRI conditional drainage systems to enable safe MRI imaging for
patients with external ventricular drains.
Market Opportunities
Rise in neurological disorder cases in developing countries due to growing life
expectancy and changing lifestyle represents a major market opportunity.
Favorable reimbursement policies for drainage procedures in U.S. and Europe
also opens growth avenues. Development of wireless CSF monitoring systems can further
support early diagnosis and effective management of hydrocephalus and related
conditions.
The Global External Ventricular Drain market witnessed a significant decline in
growth during the COVID-19 pandemic. With hospitals prioritizing the treatment of
COVID patients, several elective surgeries and procedures were postponed. This
led to a reduction in demand for external ventricular drains. Furthermore,
travel restrictions affected the supply chain and logistics of key players.
Factors like lockdowns, social distancing norms, disrupted production also
hampered the market growth temporarily. However, as the pandemic is brought
under control with vaccination drives, the market is expected to regain
momentum. Key players are focusing on addressing backlogs and increasing
production capacity. Teleconsultations and improved accessibility of aftercare
services are being emphasized to make up for delays during the pandemic.
Medical device companies are also investing in innovation and product
development catering to evolving patient needs in the post-COVID era.
The market for external ventricular drains in North America accounted for the
largest share globally in terms of value in 2024. This can be attributed to
factors like rising incidence of neurological disorders, advanced healthcare
infrastructure and growing elderly population susceptible to hydrocephalus and
brain hemorrhage. Asia Pacific is poised to be the fastest growing regional
market between 2024-2031. This growth can be credited to increasing healthcare
spending, rising medical tourism, growing patient awareness and improving
access to healthcare facilities in emerging Asian economies. Countries like
China and India with their large population bases and unmet demand present
lucrative opportunities for market players in the external ventricular drains
segment.
The external ventricular drain market in Europe holds significant value
concentration. Presence of major players, robust reimbursement policies,
universal healthcare coverage and availability of skilled neurosurgeons support
the large market size of the region. Within Europe, Germany, France and UK
individually generate higher revenue than other countries owing to their
well-established medical technologies industry and favorable business environment.
However, the market is witnessing faster growth rates in Eastern European
nations as they work towards closing the healthcare infrastructure gap with
Western European countries.
Get more insights on This Topic- Global External Ventricular Drain Market

Comments
Post a Comment